# Christina Fournier

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/christina-fournier/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,487 |
| Field | Amyotrophic Lateral Sclerosis Research |
| h-index | 22 |
| i10-index | 38 |
| Last Known Institution | Emory University |
| OpenAlex ID | https://openalex.org/A5031471524 |
| ORCID iD | 0000-0002-1561-2419 |
| Works | 74 |

## Researcher papers

- [Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis](https://scholariq.org/papers/trial-of-sodium-phenylbutyrate-taurursodiol-for-amyotrophic-lateral-sclerosis/)
- [Poly(GP) proteins are a useful pharmacodynamic marker for <i>C9ORF72</i> -associated amyotrophic lateral sclerosis](https://scholariq.org/papers/poly-gp-proteins-are-a-useful-pharmacodynamic-marker-for-i-c9orf72-i-associated/)
- [Long‐term survival of participants in the <scp>CENTAUR</scp> trial of sodium phenylbutyrate‐taurursodiol in <scp>amyotrophic lateral sclerosis</scp>](https://scholariq.org/papers/long-term-survival-of-participants-in-the-scp-centaur-scp-trial-of-sodium/)
- [Transplantation of spinal cord–derived neural stem cells for ALS](https://scholariq.org/papers/transplantation-of-spinal-cord-derived-neural-stem-cells-for-als/)
- [Randomized phase 2 trial of NP001, a novel immune regulator](https://scholariq.org/papers/randomized-phase-2-trial-of-np001-a-novel-immune-regulator/)
- [Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population](https://scholariq.org/papers/comparative-analysis-of-c9orf72-and-sporadic-disease-in-an-als-clinic-population/)
- [Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS)](https://scholariq.org/papers/development-and-validation-of-the-rasch-built-overall-amyotrophic-lateral/)
- [Predicting disease progression in amyotrophic lateral sclerosis](https://scholariq.org/papers/predicting-disease-progression-in-amyotrophic-lateral-sclerosis/)
- [Gut microbiome differences between amyotrophic lateral sclerosis patients and spouse controls](https://scholariq.org/papers/gut-microbiome-differences-between-amyotrophic-lateral-sclerosis-patients-and/)
- [Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial](https://scholariq.org/papers/effect-of-sodium-phenylbutyrate-taurursodiol-on-tracheostomy-ventilation-free/)
- [Healthcare resource utilization at different stages of amyotrophic lateral sclerosis: Results from a real-world survey](https://scholariq.org/papers/healthcare-resource-utilization-at-different-stages-of-amyotrophic-lateral/)

## Researcher topics

- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Neurogenetic and Muscular Disorders Research](https://scholariq.org/topics/neurogenetic-and-muscular-disorders-research/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

## Researcher university

- [Emory University](https://scholariq.org/institutions/emory-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.